Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Chemours stock
Learn how to easily invest in Chemours stock.
Chemours Co is a specialty chemicals business based in the US. Chemours shares (CC) are listed on the NYSE and all prices are listed in US Dollars. Chemours employs 6,400 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Chemours
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Chemours stock price (NYSE: CC)Use our graph to track the performance of CC stocks over time.
Chemours shares at a glance
|Latest market close||$31.47|
|52-week range||$22.41 - $44.95|
|50-day moving average||$37.72|
|200-day moving average||$32.80|
|Wall St. target price||$45.70|
|Dividend yield||$1 (3.15%)|
|Earnings per share (TTM)||$4.46|
Buy Chemours shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Chemours stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chemours price performance over time
|1 week (2022-06-28)||-0.82%|
|1 month (2022-06-02)||-29.33%|
|3 months (2022-04-05)||-3.50%|
|6 months (2022-01-05)||-10.60%|
|1 year (2021-07-02)||-11.45%|
|2 years (2020-07-02)||100.83%|
|3 years (2019-07-05)||48.09%|
|5 years (2017-07-05)||39.3|
Is Chemours stock undervalued or overvalued?
Valuing Chemours stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemours's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chemours's P/E ratio
Chemours's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Chemours shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Chemours's PEG ratio
Chemours's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4075. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemours's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chemours's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.
The EBITDA is a measure of a Chemours's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6.7 billion|
|Operating margin TTM||13.05%|
|Gross profit TTM||$1.4 billion|
|Return on assets TTM||7.41%|
|Return on equity TTM||73.9%|
|Market capitalisation||$5 billion|
TTM: trailing 12 months
Chemours share dividends
Dividend payout ratio: 21.1% of net profits
Recently Chemours has paid out, on average, around 21.1% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemours shareholders could enjoy a 3.15% return on their shares, in the form of dividend payments. In Chemours's case, that would currently equate to about $1 per share.
While Chemours's payout ratio might seem low, this can signify that Chemours is investing more in its future growth.
Chemours's most recent dividend payout was on 14 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2022 (the "ex-dividend date").
Chemours share price volatility
Over the last 12 months, Chemours's shares have ranged in value from as little as $22.4113 up to $44.947. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemours's is 1.7945. This would suggest that Chemours's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors.
Chemours in the news
Here's Why Chemours (CC) is a Strong Value Stock
Chemours Titanium Technologies Uses Responsible Mining to Access Critical Minerals
Ensuring a Coherent Pathway to Decarbonize EU Buildings
Frequently asked questionsWhat percentage of Chemours is owned by insiders or institutions?
Currently 1.037% of Chemours shares are held by insiders and 78.077% by institutions. How many people work for Chemours?
Latest data suggests 6,400 work at Chemours. When does the fiscal year end for Chemours?
Chemours's fiscal year ends in December. Where is Chemours based?
Chemours's address is: 1007 Market Street, Wilmington, DE, United States, 19899 What is Chemours's ISIN number?
Chemours's international securities identification number is: US1638511089 What is Chemours's CUSIP number?
Chemours's Committee on Uniform Securities Identification Procedures number is: 163851108
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert